Markets
Nutriband Inc. (NTRB)
NTRBNASDAQ-CMIndustrial Specialties
$5.59
-0.3100 (-5.25%) today
Closed, Nov 17, 4:00 PM ET
-5.25% 1D
- Market cap
- $70.62m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $2.80 to $9.19
- Average volume
- –
- Previous close
- $5.90
Earnings
Next report Dec 9, 2026
Financials
| Quarter | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| Revenue | $346.0k | $401.0k | $433.0k | $438.0k |
| Gross profit | $69.0k | $89.0k | $197.0k | $182.0k |
| Operating income | -$3.88m | -$1.02m | -$1.25m | -$891.0k |
| Net income | -$3.87m | -$968.0k | -$1.24m | -$881.0k |
Last four quarters: revenue $1.62m, margin -430.4%, free cash flow –
News
8 latest- Nutriband Seeks New Patent Protection For AVERSA Transdermal Technology RTTNews · Oct 8, 2026
- Nutriband Stock Jumps 17% After Agreement To Sell 90% Of Pocono Pharma For $5 Mln RTTNews · Dec 29, 2025
- Nutriband To Sell A 90% Stake In Pocono Pharma For $5 Million To EarthVision Bio RTTNews · Dec 29, 2025
- MediWound (MDWD) Reports Q3 Loss, Misses Revenue EstimatesZacks · Nov 20, 2025
- TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue EstimatesZacks · Nov 13, 2025
- Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue EstimatesZacks · Nov 12, 2025
- Metagenomi (MGX) Reports Q3 Loss, Lags Revenue EstimatesZacks · Nov 11, 2025
- Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass EstimatesZacks · Nov 10, 2025
The company
We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
- Sector
- Health Care
- Industry
- Industrial Specialties
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- nutriband.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.